Clinical Trials Logo

Filter by:
NCT ID: NCT01836653 Completed - Clinical trials for Liver Only Metastasis From KRAS Exon 2 Wild Type (Under Protocol 1.0-1.2 Edition) and RAS Wild Type (Under Protocol 2.0 Edition) Colorectal Cancer

Achievement of Improved Survival by Molecular Targeted Chemotherapy and Liver Resection for Not Optimally Resectable Colorectal Liver Metastases

ATOM
Start date: May 2013
Phase: Phase 2
Study type: Interventional

The purpose of this study is to evaluate efficacy and safety of mFOLFOX6+bevacizumab and mFOLFOX6+cetuximab for liver only metastasis from KRAS Exon 2 wild type (under protocol 1.0-1.2 edition) and RAS wild type (under protocol 2.0 edition) colorectal cancer.

NCT ID: NCT01835847 Completed - Depression Clinical Trials

An Open Study of Tipepidine Hibenzate in Adolescent Patients With Depression

Start date: April 2013
Phase: Phase 2
Study type: Interventional

Accumulating evidence suggests a role of G protein-coupled inwardly-rectifying potassium (GIRK) channel in the pathology of excitement of nerve, and the medicine with the action (like the Tipepidine Hibenzate) is expected as a new curative medicine of adolescent depression. The purpose of this research is to confirm the effect by carrying out the additional dosage of the Tipepidine Hibenzate to the adolescent patients with depression. If suggestion is obtained by this research about the effect on adolescent patients with depression of Tipepidine Hibenzate, it can contribute to development of the medical treatment of adolescent patients with depression.

NCT ID: NCT01835470 Completed - Clinical trials for Juvenile Idiopathic Arthritis

Efficacy, Safety, Pharmacokinetics and Immunogenicity Study of Abatacept Administered Intravenously to Treat Active Polyarticular-course Juvenile Idiopathic Arthritis in Japan

Start date: August 9, 2013
Phase: Phase 3
Study type: Interventional

The purpose of this study is to assess the efficacy of Abatacept after intravenous administration in Japanese children and adolescents with active juvenile idiopathic arthritis who have a history of an inadequate response or intolerance to Methotrexate or biologics

NCT ID: NCT01835093 Completed - Clinical trials for Attention Deficit Disorder With Hyperactivity

An Open Study of Tipepidine Hibenzate in Patients With Attention Deficit Hyperactivity Disorder (ADHD)

Start date: April 2013
Phase: Phase 2
Study type: Interventional

Accumulating evidence suggests a role of G protein-coupled inwardly-rectifying potassium (GIRK) channel in the pathology of excitement of nerve, and the medicine with the action (like the Tipepidine Hibenzate) is expected as a new curative medicine of Attention Deficit / Hyperactivity Disorder (AD/HD). The purpose of this research is to confirm the effect by carrying out the additional dosage of the Tipepidine Hibenzate to the AD/HD patients. If suggestion is obtained by this research about the effect on AD/HD of Tipepidine Hibenzate, it can contribute to development of the medical treatment of AD/HD.

NCT ID: NCT01834976 Completed - Clinical trials for Congenital Heart Disease

Cardiac Biomarker in Pediatric Heart Disease

Start date: November 2012
Phase: N/A
Study type: Observational

The purpose of this study is to investigate cardiac biomarker during perioperative management in pediatric cardiac surgery.

NCT ID: NCT01834963 Recruiting - Clinical trials for Hepatocellular Carcinoma

P2 Study of Postoperative Interferon/Fluorouracil vs Cisplatin/Fluorouracil for Hepatocellular Carcinoma.

Start date: March 2013
Phase: Phase 2
Study type: Interventional

To evaluate the efficacy and safety of postoperative hepatic arterial infusion chemotherapy, interferon/fluorouracil versus low-dose cisplatin/fluorouracil, in patients with hepatocellular carcinoma with portal vein tumor thrombus.

NCT ID: NCT01834014 Completed - Colorectal Cancer Clinical Trials

Exploratory Study in Achievement of Improved Survival by Molecular Targeted Chemotherapy and Liver Resection for Not Optimally Resectable Colorectal Liver Metastases

ATOM ES
Start date: May 2013
Phase: N/A
Study type: Interventional

The correlation between the values of angiogenesis-related growth factors in plasma and efficacy, and biomarkers relevant as prognostic factors or predictive factors for sensitivity or resistance to treatment will be examined exploratively.

NCT ID: NCT01833546 Completed - Pancreatic Cancer Clinical Trials

A Japanese Phase 1 Trial of TH-302 in Subjects With Solid Tumors and Pancreatic Cancer

Start date: April 18, 2013
Phase: Phase 1
Study type: Interventional

This is a Japanese Phase 1, open-label, and dose-escalating trial of TH-302 as monotherapy in subjects with solid tumors and in combination with gemcitabine in subjects with pancreatic cancer.

NCT ID: NCT01833494 Completed - Clinical trials for Hemodialysis Patients With Hyperphosphatemia

A Long-term Study of PA21 in Hemodialysis Patients With Hyperphosphatemia

Start date: March 18, 2013
Phase: Phase 3
Study type: Interventional

The purpose of this study is to investigate the safety and efficacy for 52-week dosing in hemodialysis patients with hyperphosphatemia.

NCT ID: NCT01832506 Completed - Solid Tumors Clinical Trials

A Japanese Phase 1 Trial of c-Met Inhibitor MSC2156119J in Subjects With Solid Tumors

Start date: April 30, 2013
Phase: Phase 1
Study type: Interventional

This is a Japanese multicenter, open-label, Phase 1 study to evaluate safety and efficacy of MSC2156119J in subjects with malignant solid tumor which is refractory to standard therapy or to which no effective standard therapy is applicable.